Verastem Oncology to Report Third Quarter 2026 Financial Results on November 5, 2026

Go back to Verastem Oncology to Report Third Quarter 2026 Financial Results on November 5, 2026
VERASTEM SHS (NASDAQ: VSTM) Delayed: 10.06 +0.85 (9.23%)
Previous Close $9.21    52 Week High $2.43 
Open $9.20    52 Week Low $1.05 
Day High $10.11    P/E N/A 
Day Low $9.14    EPS $-1.79 
Volume 5,947,213